Latest News about ALZN
Recent news which mentions ALZN
   GRTX Stock Alert: The Surprising News That Has Galera Therapeutics Going Gangbusters Today
   
  
  
  December 14, 2021
  From InvestorPlace
 From InvestorPlace
 
   ALZN Stock Alert: What Is Going on With Alzamend Neuro Today?
   
  December 14, 2021
  Tickers 
   ALZN
  
  
  From InvestorPlace
 From InvestorPlace
 
   20 Stocks Moving in Tuesday's Pre-Market Session
   
  
  
  December 14, 2021
  From Benzinga
 
   28 Stocks Moving in Thursday's Pre-Market Session
   
  
  
  November 11, 2021
  From Benzinga
 
   76 Biggest Movers From Yesterday
   
  
  
  November 11, 2021
  From Benzinga
 
   92 Biggest Movers From Friday
   
  
  
  November 08, 2021
  From Benzinga
 
   Potential Trade Setups for next week
   
  
  
  November 07, 2021
  From AC Investor Blog
 
   ALZN Stock: Why Is Little-Known Alzamend Neuro Gaining Today?
   
  November 05, 2021
  Tickers 
   ALZN
  
  
  From InvestorPlace
 
   64 Stocks Moving In Friday's Mid-Day Session
   
  
  
  November 05, 2021
  From Benzinga
 
   54 Biggest Movers From Friday
   
  
  
  October 04, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
   
  
  
  October 01, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
   
  
  
  October 01, 2021
  From Benzinga
 From InvestorPlace
 
   51 Biggest Movers From Yesterday
   
  
  
  October 01, 2021
  From Benzinga
 
   Robinhood News: HOOD Stock Dips as #CitadelScandal Trends on Twitter
   
  
  
  September 30, 2021
  From InvestorPlace
 
   ALZN Stock: The Alzheimer’s Clinical Trial News That Has Alzamend Neuro Soaring Today
   
  
  
  September 30, 2021
  From InvestorPlace
 
   36 Stocks Moving In Thursday's Mid-Day Session
   
  
  
  September 30, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
   
  
  
  September 30, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
   
  
  
  September 23, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
   
  
  
  September 21, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
   
  
  
  September 17, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
   
  
  
  September 15, 2021
  From Benzinga
 
   The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
   
  
  
  September 14, 2021
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  August 27, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.